Regenxbio is ranked Strong Buy due to low EV, strong partnerships, royalty income, bullish trends, and buyout potential.

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

Speakers from the Muscular Dystrophy Association (MDA) highlighted 75 years of progress in understanding and treating ...

Measles is one of the most contagious diseases on Earth. The only way to contain it is vaccination uptake of least 95 per cent. Vaccine hesitancy is at the root of every measles outbreak. What’s at ...

KARACHI: Thar Foundation has organized career counselling session for students, organizing free medical camp and installing ...

New security analysis tools have led to the discovery of critical vulnerabilities in widely-deployed hospital patient monitoring devices used for tracking vital signs and providing life-saving care.

Q4 2024 Earnings Call Transcript March 20, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.24, ...

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and ...

Thar Foundation continues its commitment to community development by organising free medical camp, installation of RO plant and schedules career counselling session for students in Thar and Mithi. In ...